599 related articles for article (PubMed ID: 8627996)
21. [Analysis of lymph node metastases in early esophageal carcinoma and treatment regimens].
Li L; Liu SY; Zhu KS; Chen JQ; Ying MG
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):226-9. PubMed ID: 19615267
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of lymph node metastasis in the thoracic esophageal squamous cell carcinoma].
Zhu ZJ; Zhao YF; Hu Y; Chen LQ; Liu LX; Wu Z; Kou YL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):138-40. PubMed ID: 18646699
[TBL] [Abstract][Full Text] [Related]
23. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
Wang Z; Liu XY; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
[TBL] [Abstract][Full Text] [Related]
24. Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus.
Osugi H; Takemura M; Higashino M; Takada N; Lee S; Ueno M; Tanaka Y; Fukuhara K; Hashimoto Y; Fujiwara Y; Kinoshita H
Oncol Rep; 2003; 10(1):81-7. PubMed ID: 12469149
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of cervical lymph node recurrence in patients with esophageal squamous cell carcinoma after esophagectomy with 2-field lymph node dissection.
Lee DH; Kim HR; Kim DK; Park SI; Kim YH
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):365-71. PubMed ID: 23422046
[TBL] [Abstract][Full Text] [Related]
26. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
27. Surgical outcome of patients with thoracic esophageal cancer positive for cervical lymph nodes.
Shimada H; Shiratori T; Okazumi S; Matsubara H; Nabeya Y; Shuto K; Shimizu T; Hayashi H; Ochiai T
Hepatogastroenterology; 2007; 54(73):100-3. PubMed ID: 17419240
[TBL] [Abstract][Full Text] [Related]
28. [Clinical evaluation of cervical and superior mediastinal lymph node dissection for intrathoracic esophageal carcinoma].
Ishii Y
Nihon Kyobu Geka Gakkai Zasshi; 1993 Jan; 41(1):32-44. PubMed ID: 8459143
[TBL] [Abstract][Full Text] [Related]
29. Survival and clinical evaluation of salvage operation for cervical lymph node recurrence in esophageal cancer.
Komatsu S; Shioaki Y; Ichikawa D; Hamashima T; Kan K; Ueshima Y; Koide K; Lee CJ; Ikeda E; Mutoh F; Kurioka H; Oka T; Yamagishi H
Hepatogastroenterology; 2005; 52(63):796-9. PubMed ID: 15966207
[TBL] [Abstract][Full Text] [Related]
30. The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma.
Chen J; Liu S; Pan J; Zheng X; Zhu K; Zhu J; Xiao J; Ying M
Eur J Cardiothorac Surg; 2009 Sep; 36(3):480-6. PubMed ID: 19502077
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of the therapeutic effect of esophagectomy with extended 2-field lymph node dissection for esophageal carcinoma].
Wu CR; Xue HC; Zhu ZH; Zhang ZB; Geng CY; Ma ZK; Guo Y; Gao J
Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):630-3. PubMed ID: 20021954
[TBL] [Abstract][Full Text] [Related]
32. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
[TBL] [Abstract][Full Text] [Related]
33. Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma.
Nakamura T; Ide H; Eguchi R; Hayashi K; Ota M; Takasaki K
J Surg Oncol; 2002 Apr; 79(4):224-9. PubMed ID: 11920779
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and clinical evaluation of axillary lymph node metastasis in esophageal cancer.
Komatsu S; Ueda Y; Ichikawa D; Fujiwara H; Okamoto K; Kikuchi S; Shiozaki A; Imura K; Ohsawa R; Ochiai T; Tsubokura T; Yamagishi H
Jpn J Clin Oncol; 2007 Apr; 37(4):314-8. PubMed ID: 17553821
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
Chen G; Wang Z; Liu XY; Liu FY
Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
[TBL] [Abstract][Full Text] [Related]
36. Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection.
Kosugi S; Kanda T; Yajima K; Ishikawa T; Hatakeyama K
Ann Surg Oncol; 2011 Oct; 18(10):2961-7. PubMed ID: 21499809
[TBL] [Abstract][Full Text] [Related]
37. The range of tumor extension should have precedence over the location of the deepest tumor center in determining the regional lymph node grouping for widely extending esophageal carcinomas.
Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Yamagishi H
Jpn J Clin Oncol; 2006 Dec; 36(12):775-82. PubMed ID: 17043058
[TBL] [Abstract][Full Text] [Related]
38. [Feasibility and safety of radical mediastinal lymphadenectomy in thoracoscopic esophagectomy for esophageal cancer].
Zhang Y; Tan LJ; Feng MX; Wang H; Wang Q
Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):855-9. PubMed ID: 23291137
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer.
Osugi H; Takemura M; Takada N; Hirohashi K; Kinoshita H; Higashino M
Br J Surg; 2002 Jul; 89(7):909-13. PubMed ID: 12081742
[TBL] [Abstract][Full Text] [Related]
40. Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction.
Lerut T; Coosemans W; De Leyn P; Deneffe G; Topal B; Van de Ven C; Van Raemdonck D
Hepatogastroenterology; 1999; 46(26):717-25. PubMed ID: 10370600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
